On December 2, it was revealed in an SEC filing that Catherine T Doherty, EVP at Quest Diagnostics (NYSE:DGX) executed a significant exercise of company stock options. What Happened: Disclosed in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results